Options & Mergers Analyst Glick, Pharmaceuticals Analyst Scala and Biotech Analyst Werber review the Prometheus Biosciences and Merck deal on an Analyst/Industry Webinar to be held on April 21 at 10:30. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on RXDX:
- Biotech Alert: Searches spiking for these stocks today
- Prometheus downgraded to Equal Weight from Overweight at Wells Fargo
- Prometheus downgraded to Sector Perform from Outperform at RBC Capital
- Prometheus downgraded to Neutral from Outperform at Credit Suisse
- Prometheus downgraded to Neutral from Overweight at Piper Sandler